Enables companies to deliver on their crucial service outcomes.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Neuron7.ai enables companies to deliver on their crucial service outcomes. Their service intelligence platform delivers insights at scale, empowering service teams to make decisions based on data instead of individual experience/opinions.
Neuron7 Funding
Sign up to gain insights into Neuron7 funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series B | Sep 27, 2024 | 5M | ||
| Series B | Sep 27, 2024 | 40M | ||
| Series A | Jun 21, 2022 | 10M | ||
| Series Seed | Jul 20, 2021 | 4M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Neuron7 Management Team
Investors
Nexus Venture Partners
Battery Ventures
Smith Point Capital
Neuron7 Valuations & Financials
View real-time NPM data on Neuron7 stock including daily Neuron7 stock price estimates, valuation history, and historical share price information. Access Neuron7 financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Neuron7 pricing across six independent market signals. Looking for private company due diligence data sources on Neuron7? Get in touch to learn more.
Similar Companies
like Neuron7
Abnormal AI
Information Technology
Uses AI to enhance security through real-time risk assessment and automated remediation, protecting against phishing and social engineering attacks.
Illumio
Information Technology
Provides adaptive security platform for data centers and cloud environments, enabling dynamic policy management and traffic visualization.
Talkdesk
Information Technology
A browser-based call center software for sales, support, and marketing.
Databricks
Information Technology
Open analytics platform providing enterprise-grade data, analytics, and AI solutions at scale.
Odeko
Industrials
Mobile ordering and supply chain management platform for local cafés and eateries.
FAQ
We have answers
Neuron7 stock does not trade on public stock exchanges. Neuron7 stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Neuron7 stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Neuron7 Stock does not trade on public stock exchanges. In order to sell Neuron7 shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Neuron7 does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Neuron7 share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Neuron7 stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Neuron7 stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Neuron7 stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Neuron7 is a private company and has not had an IPO. There is currently no Neuron7 IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Neuron7 IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
